Israel’s Medial EarlySign (see here previously) has partnered US-based Geisinger to identify patients at high risk for respiratory or pulmonary diseases such as lung cancer. Their LungFlag AlgoMarker analyzes data from a patient’s electronic health record to enable early screening. … Continue reading →

Barts Health, one of the largest providers to the UK’s National Health Service, has selected the ColonFlag software from Israel’s Medial EarlySign (reported here previously) to identify members at high risk for developing colon cancer – the UK’s 4th most … Continue reading →

Israeli health company Maccabi has partnered with Israel’s Medial EarlySign (see here).  Maccabi will integrate EarlySign’s flu algorithm, which flags people at high risk of developing flu-related complications, to target them with its vaccination campaign. https://www.calcalistech.com/ctech/articles/0,7340,L-3777715,00.html

I reported previously (twice) on Israel’s Medial EarlySign and its blood test for early detection of colon cancer. Now Medial has developed an algorithm with a 64% success rate for identifying which of 645,000 prediabetics were at risk of becoming … Continue reading →

I reported on Israel’s Medial EarlySign previously (May 2015) when it was MedialCS and trialing its colon cancer early-warning algorithm (now called Colon Flag) with Israel’s Maccabi Health company. EarlySign is now designing and validating models for upper GI cancer, … Continue reading →

The PlayBeyondBio initiative has selected nine Israeli startups for its program for companies developing solutions for future challenges to healthcare systems. C2i Genomics, Nucleai, Itamar medical, Medial Earlysign, iBex, Octopus.health, Imagene, iCardio.ai and Cordio Medical. https://www.calcalistech.com/ctech/articles/0,7340,L-3912456,00.html

As reported here previously, Israel’s Medial EarlySign has partnered with Israeli health company Maccabi to identify its members with a high risk of influenza complications. The system will now be used to fast-track testing and treatment if these patients report … Continue reading →

I reported previously (see here) on Israel’s Medial EarlySign’s and its use of AI to search the data of Israeli health company Maccabi to detect patients with colon cancer. In the last 18 months, Medial’s algorithms have flagged 67 patients … Continue reading →

I reported previously (see here) on the predictive artificial intelligence (AI) systems of Israeli biotech Medial EarlySign. Its AI algorithms can now predict which sufferers of diabetes will develop kidney dysfunction within a one-year time-frame. Early treatment can then improve … Continue reading →

The lives of millions may be saved thanks to a new non-invasive test for colon cancer. Hemoglobin tests on 100,000 patients of Israel’s Maccabi Health Services have led to Israel’s MedialCS developing an algorithm that identified symptoms of early-stage colon … Continue reading →